These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 21371447)

  • 1. A comparative study on the modes of action of TAK-438, a novel potassium-competitive acid blocker, and lansoprazole in primary cultured rabbit gastric glands.
    Matsukawa J; Hori Y; Nishida H; Kajino M; Inatomi N
    Biochem Pharmacol; 2011 May; 81(9):1145-51. PubMed ID: 21371447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study comparing the antisecretory effect of TAK-438, a novel potassium-competitive acid blocker, with lansoprazole in animals.
    Hori Y; Matsukawa J; Takeuchi T; Nishida H; Kajino M; Inatomi N
    J Pharmacol Exp Ther; 2011 Jun; 337(3):797-804. PubMed ID: 21411494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1-[5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine monofumarate (TAK-438), a novel and potent potassium-competitive acid blocker for the treatment of acid-related diseases.
    Hori Y; Imanishi A; Matsukawa J; Tsukimi Y; Nishida H; Arikawa Y; Hirase K; Kajino M; Inatomi N
    J Pharmacol Exp Ther; 2010 Oct; 335(1):231-8. PubMed ID: 20624992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of a novel pyrrole derivative 1-[5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine fumarate (TAK-438) as a potassium-competitive acid blocker (P-CAB).
    Arikawa Y; Nishida H; Kurasawa O; Hasuoka A; Hirase K; Inatomi N; Hori Y; Matsukawa J; Imanishi A; Kondo M; Tarui N; Hamada T; Takagi T; Takeuchi T; Kajino M
    J Med Chem; 2012 May; 55(9):4446-56. PubMed ID: 22512618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mechanism of action of omeprazole--a survey of its inhibitory actions in vitro.
    Wallmark B; Lorentzon P; Larsson H
    Scand J Gastroenterol Suppl; 1985; 108():37-51. PubMed ID: 2988109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of the gastric H+,K+ -ATPase by plectrinone A, a diterpenoid isolated from Plectranthus barbatus Andrews.
    Schultz C; Bossolani MP; Torres LM; Lima-Landman MT; Lapa AJ; Souccar C
    J Ethnopharmacol; 2007 Apr; 111(1):1-7. PubMed ID: 17166678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclo-oxygenase-1 inhibition increases acid secretion by modulating H+,K+-ATPase expression and activation in rabbit parietal cells.
    Nandi J; Das PK; Zinkievich JM; Baltodano JD; Levine RA
    Clin Exp Pharmacol Physiol; 2009 Feb; 36(2):127-34. PubMed ID: 18759857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological profile of novel acid pump antagonist 7-(4-fluorobenzyloxy)-2,3-dimethyl-1-{[(1S,2S)-2-methyl cyclopropyl]methyl}-1H-pyrrolo[2,3-d]pyridazine (CS-526).
    Ito K; Kinoshita K; Tomizawa A; Inaba F; Morikawa-Inomata Y; Makino M; Tabata K; Shibakawa N
    J Pharmacol Exp Ther; 2007 Oct; 323(1):308-17. PubMed ID: 17630360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-throughput screening of potassium-competitive acid blockers.
    Kondo M; Kawamoto M; Hasuoka A; Kajino M; Inatomi N; Tarui N
    J Biomol Screen; 2012 Feb; 17(2):177-82. PubMed ID: 21940711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of action of AZD0865, a K+-competitive inhibitor of gastric H+,K+-ATPase.
    Gedda K; Briving C; Svensson K; Maxvall I; Andersson K
    Biochem Pharmacol; 2007 Jan; 73(2):198-205. PubMed ID: 17081503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a novel potassium-competitive acid blocker of the gastric H,K-ATPase, 1-[5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine monofumarate (TAK-438).
    Shin JM; Inatomi N; Munson K; Strugatsky D; Tokhtaeva E; Vagin O; Sachs G
    J Pharmacol Exp Ther; 2011 Nov; 339(2):412-20. PubMed ID: 21828261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of four lansoprazole dose levels and one dosage regimen of omeprazole on 24-hour intragastric pH in healthy subjects.
    Timmer W; Ripke H; Kleist P; Ehrlich A; Wieckhorst G; Lücker PW; Fuder H
    Methods Find Exp Clin Pharmacol; 1995 Sep; 17(7):489-95. PubMed ID: 8577212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lansoprazole and ethanol metabolism: comparison with omeprazole and cimetidine.
    Battiston L; Tulissi P; Moretti M; Pozzato G
    Pharmacol Toxicol; 1997 Dec; 81(6):247-52. PubMed ID: 9444664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lansoprazole: a comprehensive review.
    Zimmermann AE; Katona BG
    Pharmacotherapy; 1997; 17(2):308-26. PubMed ID: 9085323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic-pharmacodynamic study of oral lansoprazole in children.
    Tran A; Rey E; Pons G; Pariente-Khayat A; D'Athis P; Sallerin V; Dupont C
    Clin Pharmacol Ther; 2002 May; 71(5):359-67. PubMed ID: 12011821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative pharmacokinetic/pharmacodynamic study of proton pump inhibitors, omeprazole and lansoprazole in rats.
    Katashima M; Yamamoto K; Sugiura M; Sawada Y; Iga T
    Drug Metab Dispos; 1995 Jul; 23(7):718-23. PubMed ID: 7587960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical review of lansoprazole.
    Lockhart SP
    Br J Clin Pract Suppl; 1994; 75():48-55; discussion 56-7. PubMed ID: 8060802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery, synthesis, and biological evaluation of novel pyrrole derivatives as highly selective potassium-competitive acid blockers.
    Nishida H; Hasuoka A; Arikawa Y; Kurasawa O; Hirase K; Inatomi N; Hori Y; Sato F; Tarui N; Imanishi A; Kondo M; Takagi T; Kajino M
    Bioorg Med Chem; 2012 Jun; 20(12):3925-38. PubMed ID: 22579619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of five antisecretory agents acting via gastric H+/K+-ATPase.
    Bastaki SM; Chandranath I; Garner A
    J Physiol Paris; 2000; 94(1):19-23. PubMed ID: 10761684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KFP-H008 blocks gastric acid secretion through inhibiting H
    Li CY; Su M; Yan YY; Zhou L; Ao LY; Fang WR; Li YM
    Eur J Pharmacol; 2017 Sep; 810():112-119. PubMed ID: 28629736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.